Given the high curing potential, very safe profile (lethal dose not achieved), and with a suitably wide effective range (g-ng regimens) and unlimited methods of application (i.e., intraperitoneal, intragastric, in drinking water or topically, at the site of injury) (for review, see [1,3,4,5,6,8,9,32,33,34])), it may be a real challenge for further therapy
That said, most published studies have used injection methods, and oral bioavailability in humans has not been clinically established
StatPearls notes that high-dose oral B has been shown effective for maintenance, but recommendations are to always use the parenteral route in severe neurological manifestations
The broader weight loss peptide landscape AOD 9604 and tirzepatide do not exist in isolation
Allow to reach room temperature for 5 minutes before opening
Research interest in AOD9604 comes from its ability to help evaluate pathway behavior, receptor or target response, formulation stability, and analytical performance under controlled laboratory conditions